Non solo DOAC: la giungla del laboratorio
Di Stefania Cavazza | 24 Agosto 2022 | 0
Ultima modifica: 26 Novembre 2024
Se misurare la concentrazione plasmatica dei farmaci anticoagulanti orali diretti (DOACs) può...
CLOT+ RSS Feed- Incidence, Risk factors, and Outcomes of Thromboembolism in Patients with Melanoma Receiving Immune Checkpoint Inhibitors, Chemotherapy, or Targeted Therapy: a SEER-Medicare Analysis.J Thromb Haemost. 2026 Sep 12:S1538-7836(26)00565-9. doi: 10.1016/j.jtha.2026.09.005.
- Prophylactic vs Therapeutic Anticoagulation in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.JAMA Netw Open. 2026 Sep 1;9(9):e2635333. doi: 10.1001/jamanetworkopen.2026.35333.
- Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Stroke: A Systematic Review and Meta-Analysis.Neurology. 2026 Oct 13;107(7):e218521. doi: 10.1212/WNL.0000000000218521. Epub 2026 Sep 16.